Thrombotic and bleeding complications associated with chemotherapy

Brandon J. McMahon, Hau C. Kwaan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

It is well recognized that cancer patients have an increased risk of thrombosis and bleeding. Contributory factors to thrombotic complications include prothrombotic risks carried by many chemotherapeutic agents, type of cancer, stage of cancer, age, and comorbidities. Surgical procedures and the presence of an indwelling vascular device, often used as a mode of delivery for chemotherapy, further increase the risk. Correlative studies have demonstrated upregulation of coagulation in response to chemotherapeutics, and clinical studies have shown that various cancer treatments are independent risk factors for thrombotic complications. It has also been shown that patients who develop thrombosis during treatment have a worse overall prognosis. Mechanisms for chemotherapy and cancer-associated thrombosis are not well understood. Better insight into the mechanism for thrombosis may help better identify those cancer patients at highest risk, who may then benefit from up-front anticoagulant prophylaxis.

Original languageEnglish (US)
Pages (from-to)808-817
Number of pages10
JournalSeminars in thrombosis and hemostasis
Volume38
Issue number8
DOIs
StatePublished - Oct 12 2012

Keywords

  • adverse drug reactions
  • bleeding
  • cancer
  • chemotherapy
  • thrombosis

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Thrombotic and bleeding complications associated with chemotherapy'. Together they form a unique fingerprint.

Cite this